Roka Bioscience awarded AOAC-RI certification for Atlas STEC EG2 Combo

Roka Bioscience announced today that its Atlas STEC EG2 Combo Detection Assay has received AOAC Performance Tested Methods certification from the AOAC Research Institute (AOAC-RI). The independent laboratory study was conducted by Silliker as part of the AOAC-RI independent third- party validation process.

The Atlas STEC EG2 Combo Detection Assay is approved for the detection of E. coli O157:H7 and other non-O157:H7 Shiga toxin-producing E. coli (STEC). The assay requires only one transfer step and a single transfer tube for the detection of both E. coli O157:H7 and non-O157 STEC, according to a release from the company. The addition of the Atlas STEC EG2 Combo Assay provides a second E. coli screening option to Roka’s E. coli O157:H7 specific test as well as its assays for the detection of Listeria spp., Salmonella, and Listeria monocytogenes.

For more information, visit www.rokabio.com.